Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Times Leader
Click for weather forecast
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aerie Pharmaceuticals
(NQ:
AERI
)
19.30
USD
+0.12 (+0.63%)
Streaming Delayed Price
Updated: 2:19 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aerie Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Today 8:01 EST
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MCRB
TERN
Penny Stocks
From
Benzinga
Looking Into Aerie Pharmaceuticals's Return On Capital Employed
March 01, 2021
During Q4, Aerie Pharmaceuticals's (NASDAQ:AERI) reported sales totaled $24.68 million. Despite a 5.92% in earnings, the company ...
Tags
Market News
News
AERI
From
Benzinga
72 Biggest Movers From Friday
March 01, 2021
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 48% to close at $5.58 on Friday. Lixte Biotech recently ...
Tags
TPC
Small Cap
CLW
From
Benzinga
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 25, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
VIR
GKOS
HZNP
From
Benzinga
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
February 22, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ...
Tags
MMSI
ZGNX
JAZZ
From
Benzinga
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021
February 18, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Math Shows IHE Can Go To $215
February 12, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aerie Pharmaceuticals Receives European Commission Approval for Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%
January 11, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Analysts Predict 15% Upside For The Holdings of IHE
January 07, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Bullish Two Hundred Day Moving Average Cross - AERI
December 15, 2020
In trading on Tuesday, shares of Aerie Pharmaceuticals Inc (AERI) crossed above their 200 day moving average of $13.09, changing hands as high as $13.12 per share. Aerie Pharmaceuticals Inc shares are...
Tags
Stocks
From
Market News Video
First Week of AERI January 2021 Options Trading
December 10, 2020
Investors in Aerie Pharmaceuticals Inc (AERI) saw new options begin trading this week, for the January 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AERI...
Tags
Stocks
From
Market News Video
The Math Shows IHE Can Go To $210
December 07, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union
November 13, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
November 10, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
November 05, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ATNX
CALA
ATHA
From
Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
HAE
OTIC
UROV
From
Benzinga
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
October 29, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries
October 28, 2020
Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive development and commercialization...
From
Business Wire News Releases
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call on Thursday, November 5, 2020
October 27, 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients...
From
Business Wire News Releases
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ATXI
Penny Stocks
GMAB
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 21, 2020
Before 10 a.m. ET on Wednesday, 21 companies set new 52-week lows. Noteables: Equity Commonwealth (NYSE: EQC) was the ...
Tags
Movers
BMA
Benzinga
From
Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
LH
XTLB
INSM
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 20, 2020
Before 10 a.m. ET Tuesday, 14 stocks made new 52-week lows. Significant Points: The company with the largest market ...
Tags
CRBP
ICPT
BXRX
From
Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ALDX
Penny Stocks
TARS
From
Benzinga
58 Biggest Movers From Yesterday
October 20, 2020
Gainers Kaixin Auto Holdings (NASDAQ: KXIN) shares climbed 293.7% to close at $8.15 on Monday after climbing over 55% on Friday. ...
Tags
Markets
LQDA
OBLG
From
Benzinga
Mid-Afternoon Market Update: Dow Falls 250 Points; BioSpecifics Technologies Shares Spike Higher
October 19, 2020
Toward the end of trading Monday, the Dow traded down 0.90% to 28348.53 while the NASDAQ fell 0.92% to 11564.13. The S&P also fell, ...
Tags
Market News
AXAS
KXIN
From
Benzinga
10 Healthcare Stocks Moving In Monday's Intraday Session
October 19, 2020
Gainers BOQI International (NASDAQ:BIMI) stock increased by 60.05% to $3.1 during Monday's regular session. Trading volume for ...
Tags
Movers
AERI
RWLK
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.